Our Background
We offer expert consultation in strategic research, development, manufacturing, and CMC, specializing in small molecules, peptides, proteins, plasmids, and cell & gene therapies. From early-stage development through clinical trials to full commercialization, we help bring life-changing therapies to market faster.
Team
Nayaz Ahmed, PhD, RAC (US, EU), CQA, Six Sigma Green Belt
Founder & Principal
Nayaz Ahmed brings 25 years of expertise in pharma, biotech, and medical devices, spearheading small molecule, peptide, protein, and plasmid-based drug development from concept to commercialization. With a PhD in Organic Chemistry and certifications in RAC (US, EU), CQA, and Six Sigma, he founded Indigo Life Science (formerly CQPS) to deliver innovative CMC and quality solutions. Passionate and dedicated, Nayaz excels at aligning teams to meet FDA, EU, ICH, and ISO standards, guiding inspections, and driving regulatory excellence.
Uma Lakshmipathy, Phd
Scientific Advisor & Founding Visionary
Uma Lakshmipathy offers 25+ years in R&D—spanning corneal stroma proteins, stem cells, and cell/gene therapy—as Site Head for Thermo Fisher Scientific’s Cell and Gene Therapy Division. A 2025 ISSCR Public Service Award Honoree with numerous patents and publications, she advises scientific boards, including paid SAB roles, shaping industry innovation. Uma lends strategic insight to Indigo Life Science, amplifying its mission with her expertise and shared passion for impactful work.
Our Combined Impact
Together, Nayaz and Uma unite over 50 years of experience, 10+ patents, and 100+ publications, blending CMC, quality, and cell/gene therapy leadership to advance innovative solutions across pharma, biotech, and medical devices. For them, work is a lifelong passion, fueling happiness and excellence.
Disclaimer: Drug approval contributions reflect Nayaz Ahmed’s consulting support to CDMOs and clients for CMC and quality activities, not direct sponsorship by Indigo Life Science. Uma Lakshmipathy’s role is limited to strategic scientific guidance, consistent with her Thermo Fisher Scientific-approved SAB activities, and does not involve active consulting for Indigo clients